Related Experiment Videos
Is the level of arterial pressure reduction important for preservation of renal function
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Renal Targeted Therapies of Antihypertensive and Cardiovascular Drugs for Patients With Stages 3 Through 5d Kidney Disease.
Clinical pharmacology and therapeutics·2017
Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies.
Clinical pharmacology and therapeutics·2014
Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program.
Internal medicine journal·2011
Limitations of metformin use in patients with kidney disease: are they warranted?
Diabetes, obesity & metabolism·2010
The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented.
Journal of human hypertension·2009
Beyond Kt/V: Redefining Dialysis Adequacy as Targeted Cardiovascular Risk Reduction.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Obesity and chronic kidney disease: a cardio-kidney-metabolic framework for renal vulnerability and risk stratification.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Unmet Needs in the Management of Adult Patients with Lupus Nephritis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
European epidemiology of kidney cancer.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
FGF23 blockade induces maladaptive vascular remodelling, reducing pathologically increased arterial stiffness and blood pressure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Sparsentan - SGLT2 inhibitor combination therapy in trials of IgA nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026